Registered Nurse in Deptford, NJ Accepting Medicare

4 Registered Nurse nurses found. Showing 1 - 4

Derrae Fornito, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 600 1st Ave, Deptford, NJ 08096 Phone: 800-950-6066

Erika Archilla, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 309 Chancellor Dr, Deptford, NJ 08096 Phone: 800-950-6066

Theresa Clayton, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 339 Warwick Rd, Deptford, NJ 08096 Phone: 800-950-6066

Alyssa Sue Destefano, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 816 Hancock Ct, Deptford, NJ 08096 Phone: 856-340-0517

News Archive

National study highlights successful partnership between First Nations peoples across Canada and academia

The University of Ottawa, the University of Montreal and the Assembly of First Nations are pleased to announce the newly published First Nations Food, Nutrition and Environment Study (FNFNES) in the Canadian Journal of Public Health.

Low birth weight associated with low levels of social trust in adulthood

How much does your baby weigh? All new parents are familiar with that question. Perhaps their reply is more important than we realize. Birth weight affects how much trust an individual will have in other people in his adult life. Trust, in turn, is the glue that prevents society from falling apart. This phenomenon is at the center of new research from Aarhus School of Business and Social Sciences (Aarhus BSS) at Aarhus University, Denmark.

U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX

Merck said today that U.S. District Court Judge John F. Keenan granted summary judgment in Merck's favor in Flemings v. Merck. Flemings is the second of three cases involving FOSAMAX (alendronate sodium) designated by the federal MDL court as a bellwether trial case.

Inpatient PSA levels ‘should be disregarded' for prostate monitoring

Researchers from Korea say that inpatient prostate-specific antigen levels should be ignored for the purposes of serial monitoring, after finding that they are significantly reduced compared with outpatient levels.

Labopharm launches antidepressant OLEPTRO for major depressive disorder in U.S.

Labopharm Inc. today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, has been launched in the United States by its joint venture with Gruppo Angelini, Angelini Labopharm. OLEPTRO(TM) is indicated for the treatment of major depressive disorder (MDD) in adults. The efficacy of OLEPTRO(TM) has been established in a trial of outpatients with MDD as well as in trials with the immediate release formulation of trazodone.

Read more Medical News

› Verified 6 days ago